Apricus Biosciences, Inc.
(NASDAQ : APRI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
7.39%18.612.0%$261.54m
SHPGShire PLC Sponsored ADR
-0.24%175.820.4%$246.96m
JAZZJazz Pharmaceuticals Plc
1.85%148.322.2%$114.90m
PRGOPerrigo Co. Plc
1.11%61.106.8%$102.30m
ENDPEndo International Plc
-0.16%12.518.9%$62.97m
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.77%123.356.3%$61.16m
MNKMallinckrodt Plc
1.29%28.3621.1%$55.95m
ICPTIntercept Pharmaceuticals, Inc.
2.06%108.9518.7%$54.52m
SAGESAGE Therapeutics, Inc.
0.35%107.779.6%$54.31m
HZNPHorizon Pharma plc
0.49%20.677.4%$52.35m
UTHRUnited Therapeutics Corporation
1.03%114.3814.4%$47.27m
CTLTCatalent Inc
0.90%37.942.4%$41.74m
ICLRICON Plc
2.39%131.344.1%$35.12m
PTLAPortola Pharmaceuticals, Inc.
2.33%19.737.7%$34.52m
AERIAerie Pharmaceuticals, Inc.
5.46%43.296.9%$30.49m

Company Profile

Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA.